Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect
Journal Title
Loading...
Issue Date
2009-01-09
Authors
Medical Center Staff
Publisher
Stony Brook Medicine, Stony Brook University
Keywords
Abstract
Description
DOI
Collections
Content Designation
Archived web content